InsidersTradesSigma
엘앤씨바이오: directors' dealings · South Korea · DART (FSS)
DART:company-ed4cf7KR·DART (FSS)Mcap 1466.3Bn€Healthcare
Explore the full insider trade history of 엘앤씨바이오, a listed equity based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Healthcare sector, 엘앤씨바이오 has published 2 reports. Market capitalisation: €1,466.3bn. The latest transaction was disclosed on 16 April 2026 — Other. Among the most active insiders: 이환철. The full history is free.
2
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
60300.00 €
Analyst consensus
2 analystsStrong buy
80000.00 €Target 88000.00 €(+46%)96000.00 €
Income statement
Revenue85.48 Bn€
Gross profit45.39 Bn€53% margin
Net income−138.17 Bn€-161.7% margin
Valuation
PER (forward)25.8x
Beta1.34
Balance sheet & cash
Market cap1466.29 Bn€
Total debt92.20 Bn€
Free Cash Flow−4.47 Bn€
Debt / Equity44%
Profitability & ownership
ROE-55.4%
ROA0.5%
% insiders24.6%
% institutions13.2%
Last declaration on 16 April 2026